×
| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 09 Feb 2026 | Choice Institutional Equities | Buy | ₹177.15 | ₹225 | 20.5% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Marksans Pharma Limited | 7745.71 | 1136.9 | 7544.27 | 2.5 | 7,449 | 21.3 |
| FDC Limited | 4855.06 | 283.03 | 4647.08 | 1.74 | 7394 | 27.5 |
| Akums Drugs and Pharmaceuticals Limited | 11939.15 | 676.74 | 11595.87 | 4.33 | 7030 | 21.3 |
Marksans Pharma Ltd., with Security Code 524404, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 204.7 | 241.4 | 225.2 | 254.5 | 308.6 | 311.9 | 299.4 | 319.7 |
| Expenses | 167.4 | 199.4 | 191.3 | 213.3 | 256.4 | 251.9 | 248.7 | 249.7 |
| Operating Profit | 37.3 | 42.0 | 33.9 | 41.3 | 52.3 | 59.9 | 50.6 | 70.1 |
| OPM % | 18.22% | 17.39% | 15.06% | 16.21% | 16.94% | 19.22% | 16.92% | 21.91% |
| Other Income | 15.9 | 1.3 | 12.2 | 8.2 | 31.4 | 22.5 | 7.8 | 2.0 |
| Interest | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Depreciation | 8.5 | 8.4 | 7.5 | 6.8 | 7.0 | 7.4 | 8.2 | 8.2 |
| Profit before tax | 44.5 | 34.6 | 38.4 | 42.3 | 76.3 | 74.7 | 50.0 | 63.6 |
| Tax % | -29.7% | -26.9% | -14.1% | 24.3% | -17.2% | -25.8% | -24.6% | 24.4% |
| Net Profit | 31.3 | 25.3 | 33.0 | 32.0 | 63.2 | 55.5 | 37.6 | 48.1 |
| EPS in Rs | 0.69 | 0.56 | 0.73 | 0.71 | 1.39 | 1.22 | 0 | 1.06 |
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 560.0 | 590.6 | 641.9 | 681.8 | 70.8 | 720.4 | 754.4 | 754.4 |
| Expenses | 450.4 | 462.2 | 506.2 | 543.1 | 58.2 | 575.9 | 593.7 | 593.7 |
| Operating Profit | 109.6 | 128.4 | 135.7 | 138.8 | 12.7 | 144.5 | 160.7 | 160.7 |
| OPM % | 19.58% | 21.75% | 21.14% | 20.35% | 17.88% | 20.06% | 21.31% | 21.31% |
| Other Income | 16.5 | 14.9 | 11.1 | 27.8 | 1.7 | 21.6 | 20.1 | 20.1 |
| Interest | 4.8 | 2.9 | 2.6 | 2.7 | 0.3 | 5.8 | 5.9 | 5.9 |
| Depreciation | 21.1 | 20.4 | 19.5 | 20.7 | 2.3 | 26.9 | 24.3 | 24.3 |
| Profit before tax | 100.3 | 120.0 | 124.6 | 143.3 | 11.7 | 133.3 | 150.6 | 150.6 |
| Tax % | -22.6% | -25.8% | 21.5% | 26.7% | -21.5% | 25.6% | 24.5% | 24.5% |
| Net Profit | 77.6 | 89.1 | 97.8 | 105.1 | 9.1 | 99.1 | 113.7 | 113.7 |
| EPS in Rs | 1.73 | 1.96 | 2.13 | 2.31 | 0 | 2.17 | 2.5 | 2.5 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 38% |
| 3 Years: | 22% |
| TTM: | 41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 66% |
| 3 Years: | 72% |
| 1 Year: | 46% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 18% |
| 3 Years: | 21% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 26% |
| 3 Years: | 27% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 66% |
| 3 Years: | 72% |
| 1 Year: | 46% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|